T2 Biosystems, Inc. (NASDAQ:TTOO – Get Free Report) saw a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 834,800 shares, a growth of 47.4% from the October 15th total of 566,500 shares. Based on an average daily volume of 448,000 shares, the days-to-cover ratio is presently 1.9 days. Approximately 14.4% of the shares of the company are short sold.
Analyst Ratings Changes
TTOO has been the subject of a number of analyst reports. Canaccord Genuity Group boosted their price objective on T2 Biosystems from $3.00 to $5.00 and gave the company a “hold” rating in a research report on Tuesday, July 30th. StockNews.com raised shares of T2 Biosystems to a “sell” rating in a report on Tuesday, July 30th.
Get Our Latest Report on T2 Biosystems
Hedge Funds Weigh In On T2 Biosystems
T2 Biosystems Stock Performance
NASDAQ TTOO opened at $0.50 on Friday. The company has a 50-day moving average price of $1.51 and a two-hundred day moving average price of $3.49. T2 Biosystems has a 52 week low of $0.44 and a 52 week high of $8.38.
T2 Biosystems Company Profile
T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.
Featured Articles
- Five stocks we like better than T2 Biosystems
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- When to Sell a Stock for Profit or Loss
- Time to Load Up on Home Builders?
- Industrial Products Stocks Investing
- Flutter Entertainment Can Be a Blue-Chip Sports Betting Stock
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.